AI Biosciences, Inc. SBIR Phase I Award, September 2021
A SBIR Phase I contract was awarded to AI BIOSCIENCES, INC. in September, 2021 for $243,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention.